Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD)

NCT00308074 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT00308074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD)
Lead sponsor
Cambridge Health Alliance
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
February 28, 2009
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asperger's disorder, autism, pervasive developmental disorder